海外の治験の状況「1」での検索結果
544件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Dasatinib plus Chemotherapy in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia
- Philadelphia Chromosone-Positive Acute Lymphoblastic Leukaemia (Ph+ ALL)
- Australia, New Zealand
- 2007-11-28
Recruiting
- The effect of short sprints during exercise on blood glucose management in Type 1 Diabetes Mellitus.
- Type 1 Diabetes Mellitus
- Australia
- 2016-05-05
Recruiting
- Feasibility of an Investigational Extended Wear Infusion Set for Continuous Subcutaneous Insulin Infusion (CSII) in Patients with Type 1 Diabetes Mellitus (T1DM).
- Type 1 Diabetes Mellitus; br>Type 1 Diabetes Mellitus;Metabolic and Endocrine - Diabetes
- Australia
- 2020-01-14
Recruiting
- A Phase I Study to Evaluate the Safety and Efficacy of Mesenchymal Stromal Cells (MSC) for Treating Chronic Obstructive Pulmonary Disease (COPD)
- COPD
- Australia
- 2014-07-10
Recruiting
- A phase 1 clinical trial of peptide-pulsed monocyte-derived dendritic cell vaccination to expand adoptively transferred cytomegalovirus -specific cytotoxic T lymphocytes after allogeneic stem cell transplantation
- Cytomegalovirus (CMV) reactivation and disease
- Australia
- 2008-09-15
Recruiting
- 'OCD? Not Me! Curtin On-line Obsessive-Compulsive Disorder Treatment for Young People
- Obsessive-Compulsive Disorder
- Australia
- 2013-02-08
Recruiting
- Oral NSAI Versus Placebo as a Second Line Treatment for Renal Colics
- Renal Colic
- Tunisia
- 2014-11-26
Recruiting
- Option B+: Study on Safety, Viral Suppression, and Survival on Second Line ART
- HIV;Infant Exposure to Efavirenz;HIV;Infant Exposure to Efavirenz;HIV;Infant Exposure to Efavirenz
- Malawi
- 2014-09-11
Recruiting
- A Randomized, Double-blind, Parallel-arm, Phase I Study to Evaluate the Pharmacokinetics and Pharmacodynamics of BI 695500 vs. Rituximab (MabThera) Induction Immunotherapy as a First-line Treatment in Patients With Low Tumor Burden Follicular Lymphoma
- Lymphoma, Follicular;C82 - Follicular lymphoma
- Australia, Czech Republic, France, Germany, Hungary, New Zealand
- 2014-04-17
Recruiting
- Pembrolizumab as First Line Treatment in Subjects with Recurrent/Metastatic HNSCC.
- -C760 Head, face and neck Head, face and neck;Head, face and neck
- Australia, Austria, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, Finland, Greece, Hungary, Israel, Italy, Japan, Latovia, Malasya, Netherlands, Norway, Philippines, Romania, Russian Federation, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United States
- 2015-06-05